Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C ß-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer

J.M. Rademaker-Lakhai, L.V. Beerepoot, N. Mehra, S.A Radema, R. van Maanen, J.S. Vermaat, E.O. Witteveen, C.M. Visseren-Grul, L. Musib, N. Enas, G. van Hal, J.H. Beijnen, J.H.M. Schellens, E.E. Voest

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)4474-4481
Number of pages8
JournalClinical Cancer Research
Issue number15
Publication statusPublished - 2007

Cite this